Levin Capital Strategies’s Revance Therapeutics, Inc. RVNC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q2 | – | Sell |
-9,000
| Closed | -$277K | – | 340 |
|
|
2018
Q1 | $277K | Buy |
+9,000
| New | +$277K | 0.01% | 239 |
|
|
2016
Q1 | – | Sell |
-32,511
| Closed | -$1.11M | – | 373 |
|
|
2015
Q4 | $1.11M | Sell |
32,511
-11,333
| -26% | -$387K | 0.02% | 192 |
|
|
2015
Q3 | $1.31M | Sell |
43,844
-31,417
| -42% | -$935K | 0.02% | 181 |
|
|
2015
Q2 | $2.41M | Sell |
75,261
-17,078
| -18% | -$546K | 0.04% | 156 |
|
|
2015
Q1 | $1.91M | Buy |
92,339
+4,355
| +5% | +$90.3K | 0.03% | 175 |
|
|
2014
Q4 | $1.49M | Buy |
87,984
+5,329
| +6% | +$90.2K | 0.02% | 181 |
|
|
2014
Q3 | $1.6M | Sell |
82,655
-102,111
| -55% | -$1.97M | 0.02% | 182 |
|
|
2014
Q2 | $6.28M | Buy |
184,766
+137,812
| +294% | +$4.69M | 0.1% | 129 |
|
|
2014
Q1 | $1.48M | Buy |
+46,954
| New | +$1.48M | 0.02% | 190 |
|